Should high-risk adolescents be permitted to consent to HIV pre-exposure prophylaxis in Texas?

Simple item page
dc.contributor.authorMoore, Quianta L.en_US
dc.contributor.orgJames A. Baker III Institute for Public Policyen_US
dc.date.accessioned2016-07-07T17:57:43Zen_US
dc.date.available2016-07-07T17:57:43Zen_US
dc.date.issued2016en_US
dc.descriptionHealth Policy Scholar Quianta Moore examines legal and ethical justifications for permitting high-risk adolescents to consent to HIV prevention therapy.en_US
dc.identifier.citationMoore, Quianta L.. "Should high-risk adolescents be permitted to consent to HIV pre-exposure prophylaxis in Texas?." <i>Health Policy Research newsletter,</i> 11, no. 1 (2016) James A. Baker III Institute for Public Policy;Baylor College of Medicine: <a href="http://bakerinstitute.org/research/hiv-prevention-therapy-teens/">http://bakerinstitute.org/research/hiv-prevention-therapy-teens/</a>.en_US
dc.identifier.urihttps://hdl.handle.net/1911/90817en_US
dc.publisherJames A. Baker III Institute for Public Policy;Baylor College of Medicineen_US
dc.titleShould high-risk adolescents be permitted to consent to HIV pre-exposure prophylaxis in Texas?en_US
dc.typenewslettersen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
HPR-Newsletter-March2016.pdf
Size:
1.03 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Baker Institute Publications